SARS-COV-2 GENOMIC SURVEILLANCE IN BULGARIA INDICATES DIVERSE DYNAMICS DRIVEN BY MULTIPLE INTRODUCTIONS OF DIFFERENT VIRAL VARIANTS IN 2022

Authors

  • Ivaylo Alexiev National Centre of Infectious and Parasitic Diseases Author
  • Ivan Ivanov National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria Author
  • Ivan Stoikov National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria Author https://orcid.org/0000-0002-9924-8553
  • Deyan Donchev National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria Author https://orcid.org/0000-0001-7447-7627
  • Lyubomira Grigorova National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria Author
  • Reneta Dimitrova National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria Author https://orcid.org/0000-0001-7711-6798
  • Anna Gancheva National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria Author
  • Neli Korsun National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria Author
  • Ivelina Trifonova National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria Author https://orcid.org/0000-0002-4543-6831
  • Veselin Dobrinov National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria Author
  • Todor Kantardjiev National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria Author
  • Iva Christova National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria Author

DOI:

https://doi.org/10.58395/6725v303

Keywords:

SARS-CoV-2, COVID-19, sequencing, Viral variants

Abstract

Background. Evolution of the emerging SARS-CoV-2 variants raises concerns about the possibility of accelerated transmission,  disease severity, diagnostic challenges, and reduced vaccine effectiveness in the ever-evolving COVID-19 pandemic worldwide. Objectives for this study were to build a comprehensive national system for monitoring and genomic surveillance of SARS-CoV-2  and to identify the introduced virus variants in the country.

Methods. We analyzed SARS-CoV-2 infections in 7948 representative clinical samples collected in medical institutions in different  geographical regions of the country in 2022. Whole-genome next-generation sequencing of SARS-CoV-2 was performed on samples  from randomly selected SARS-CoV-2-positive individuals by using a modified ARTIC v3-tailed amplicon method. A bioinformatic and  phylogenetic analyses of the obtained sequences was carried out.

Results. Significant dynamics was observed in the spread of viral variants in 2022, which is characterized by the introduction and  spread of multiple SARS-CoV-2 variants. The phylogenomic analysis identified a high genetic heterogeneiety composed of a total of 152 different viral clades divided into 3 main supergroups: 114 (75.0%) of which were Omicron sub-variants, 35 (23.0%) Delta sub-variants, and 3 (2.0%) recombinant forms.

Conclusion. Viral variants and their sub-clades with different potentials to impact disease severity were identified and the  information was immediately published for use by decision-makers and the scientific community. The global pandemic of COVID-19  has shown the importance of molecular biological surveillance, which is an indispensable element of the modern approach in the  fight against infectious diseases.

Downloads

Download data is not yet available.

References

Zoumpourlis V, Goulielmaki M, Rizos E, Baliou S and Spandidos DA: [Comment] The COVID 19 pandemic as a scientific and social challenge in the 21st century. Mol Med Rep 2020; 22 (4): 3035-3048. https://doi.org/10.3892/mmr.2020.11393

Kupferschmidt K. New coronavirus variants could cause more reinfections, require updated vaccines. Science, 2021. https://doi.org/10.1126/science.abg6028

Alexiev I, Ivanov I, Philipova I, Korsun N, Stoykov I, Dimitrova R, Grigorova L, Gancheva A, Trifonova I, Dobrinov V, Grigorova L, Savov A, Asenova B, Ciccozzi M, Kantardjiev T. Postvaccination SARS-CoV-2 Alpha (B. 1.1. 7) lineage infection among healthcare workers on the background of IgG antibodies. J MED VIROL 2021; https://doi.org/10.1002/jmv.27394

World Health Organization. Tracking SARS-CoV-2 variants. Geneva, Switzerland. Available from: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ (Accessed 28 february 2023).

SARS-CoV-2 Variant Classifications and Definitions, Centers for Disease Control and Prevention (CDC) https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html. (Accessed 28 february 2023).

Outbreak.info https://outbreak.info/ (Accessed 28 february 2023)

Quarleri, J., Galvan, V., & Delpino, M. V. Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load. GeroScience, 2022; 1-4. https://doi.org/10.1007/s11357-021-00500-4

Vitiello, A., Ferrara, F., Auti, A. M., Di Domenico, M., & Boccellino, M. Advances in the Omicron variant development. J. Intern. Med, 2022. 292(1), 81-90. https://doi.org/10.1111/joim.13478

Yao L, Zhu KL, Jiang XL, Wang XJ, Zhan BD, Gao HX, Geng XY, Duan LJ, Dai EH, Ma MJ. Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection. Lancet Infect Dis. 2022 Aug;22(8):1116-1117. https://doi.org/10.1016/S1473-3099(22)00410-8. Epub 2022 Jun 20. PMID: 35738299; PMCID: PMC9212811.

Bulgaria: Coronavirus Pandemic Country Profile. https://ourworldindata.org/coronavirus/country/bulgaria. (Accessed 28 february 2023).

Bulgarian Medical Association. Medical standards https://www.mh.government.bg/bg/normativni-aktove/meditsinski-standarti/Gohl M, Garbe J, Grady P, et al. A rapid, cost-effective tailed amplicon method for sequencing SARS-CoV-2. BMC Genom. 2020;21(1):1-10. https://doi.org/10.1186/s12864-020-07283-6

Gohl M, Garbe J, Grady P, et al. A rapid, cost-effective tailed amplicon method for sequencing SARS-CoV-2. BMC Genom. 2020;21(1):1-10. https://doi.org/10.1186/s12864-020-07283-6

DNA Pipelines R&D, Benjamin Farr, Diana Rajan, Emma Betteridge, Lesley Shirley, Michael Quail, Naomi Park, Nicholas Redshaw, Iraad F Bronner, Louise Aigrain, Scott Goodwin, Scott Thurston, Stefanie Lensing, James Bonfield, Keith James, Nicholas Salmon, Charlotte Beaver, Rachel Nelson, David K. Jackson, Alex Alderton, Ian Johnston. COVID-19 ARTIC v3 Illumina Library Construction and Sequencing Protocol—Tailed Method. 2022. https://doi.org/10.17504/protocols.io.bky5kxy6

Eurofinsgenomics, Germany. https://eurofinsgenomics.com/en/products/dna-sequencing/ (Accessed 28 february 2023).

Rambaut A, Holmes EC, O'Toole Á, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol. 2020;5(11):1403-1407. https://doi.org/10.1038/s41564-020-0770-5

Republic of Bulgaria – National Statistical Institute. Population by districts, municipalities, place of residence and sex. https://www.nsi.bg/en/content/2975/population-districts-municipalities-place-residence-and-sex. (Accessed 28 february 2023).

European Centre for Disease Prevention and Control. Guidance for representative and targeted genomic SARS-CoV-2 monitoring – 3 May 2021. ECDC: Stockholm; 2021. Available from: https://www.ecdc.europa.eu/en/publications-data/guidance-representative-and-targeted-genomic-sars-cov-2-monitoring

NCIPD. Graphical analysis of data from the National Information System for COVID-19, Bulgaria [in Bulgarian]. Available from https://covid19.ncipd.org/ (Accessed 28 february 2023).

SARS-CoV-2 phylogeny https://nextstrain.org/groups/neherlab/ncov/bulgaria?c=clade_membership&f_country=Bulgaria&r=division (Accessed 28 february 2023).

Karthik Gangavarapu, Alaa Abdel Latif, Julia L. Mullen, Manar Alkuzweny, Emory Hufbauer, Ginger Tsueng, Emily Haag, Mark Zeller, Christine M. Aceves, Karina Zaiets, Marco Cano, Xinghua Zhou, Zhongchao Qian, Rachel Sattler, Nathaniel L. Matteson, Joshua I. Levy, Raphael T. C. Lee, Lucas Freitas, Sebastian Maurer-Stroh, GISAID Core and Curation Team, Marc A. Suchard, Chunlei Wu, Andrew I. Su, Kristian G. Andersen & Laura D. Hughes. Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations. Nature Methods (2023). https://doi.org/10.1038/s41592-023-01769-3

Grubaugh ND, Hodcroft EB, Fauver JR, Phelan AL, Cevik M. Public health actions to control new SARS-CoV-2 variants. Cell. 2021 Mar 4;184(5):1127-32. Available at: https://www.ncbi.nlm.nih.gov/pubmed/33581746 https://doi.org/10.1016/j.cell.2021.01.044

World Health Organization. Operational considerations to expedite genomic sequencing component of GISRS surveillance of SARS-CoV-2. 2021 (WHO/2019-nCoV/genomic_sequencing/GISRS/2021.1). Licence: CC BY-NC-SA 3.0 IGO. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-genomic-sequencing-GISRS-2021.1

Brito AF, Semenova E, Dudas G, Hassler GW, Kalinich CC, Kraemer MUG, Ho J, Tegally H, Githinji G, Agoti CN, Matkin LE, Whittaker C; Bulgarian SARS-CoV-2 sequencing group; Communicable Diseases Genomics Network (Australia and New Zealand); COVID-19 Impact Project; Danish Covid-19 Genome Consortium; Fiocruz COVID-19 Genomic Surveillance Network; GISAID core curation team; Network for Genomic Surveillance in South Africa (NGS-SA); Swiss SARS-CoV-2 Sequencing Consortium; Howden BP, Sintchenko V, Zuckerman NS, Mor O, Blankenship HM, de Oliveira T, Lin RTP, Siqueira MM, Resende PC, Vasconcelos ATR, Spilki FR, Aguiar RS, Alexiev I, Ivanov IN, Philipova I, Carrington CVF, Sahadeo NSD, Branda B, Gurry C, Maurer-Stroh S, Naidoo D, von Eije KJ, Perkins MD, van Kerkhove M, Hill SC, Sabino EC, Pybus OG, Dye C, Bhatt S, Flaxman S, Suchard MA, Grubaugh ND, Baele G, Faria NR. Global disparities in SARS-CoV-2 genomic surveillance. Nat Commun. 2022 Nov 16;13(1):7003. https://doi.org/10.1038/s41467-022-33713-y

Mukherjee S, Pahan K. Is COVID-19 Gender-sensitive? J Neuroimmune Pharmacol. 2021 Mar;16(1):38-47. https://doi.org/10.1007/s11481-020-09974-z. Epub 2021 Jan 6. PMID: 33405098; PMCID: PMC7786186.

Marinov GK, Mladenov M, Rangachev A, Alexiev I. SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria. PLoS ONE (2022) 17(9): e0274509. https://doi.org/10.1371/journal.pone.0274509

Saxena SK, Kumar S, Ansari S, Paweska JT, Maurya VK, Tripathi AK, Abdel-Moneim AS. Transmission dynamics and mutational prevalence of the novel Severe acute respiratory syndrome coronavirus-2 Omicron Variant of Concern. J Med Virol. 2022 May; 94(5):2160-2166. https://doi.org/10.1002/jmv.27611. Epub 2022 Feb 4. PMID: 35050521; PMCID:PMC9015611.

Wei C, Shan KJ, Wang W, Zhang S, Huan Q, Qian W. Evidence for a mouse origin of the SARS-CoV-2 Omicron variant. J Genet Genomics. 2021 Dec;48(12):1111-1121. https://doi.org/10.1016/j.jgg.2021.12.003. Epub 2021 Dec 24. PMID:34954396; PMCID: PMC8702434.

Alkhatib M, Salpini R, Carioti L, Ambrosio FA, D'Anna S, Duca L, Costa G, Bellocchi MC, Piermatteo L, Artese A, Santoro MM, Alcaro S, Svicher V, Ceccherini-Silberstein F. Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile. Microbiol Spectr. 2022 Apr 27;10(2):e0273221. https://doi.org/10.1128/spectrum.02732-21. Epub 2022 Mar 30. PMID: 35352942; PMCID: PMC9045195.

Alexiev, I., Giovanetti, M., Cella, E., Ivanov, I., Stoikov, I., Donchev, Lubomira Grigorova, Anna Gancheva, Reneta Dimitrova, Nelly Korsun, Ivelina Trifonova, Ivva Philipova, Veselin Dobrinov, Iliana Grigorova, Todor Kantardjiev, Iva Christova, Massimo Ciccozzi. Initial Introduction and Spread of the SARS-CoV-2 AY. 4.2.1 Delta Variant in Bulgaria, a Genomic Insight. J. Med. Virol.. PMID: 35902787 https://doi.org/10.1002/jmv.28033

Downloads

Published

2023-08-14

Issue

Vol. 50 No. 3 (2022)

Section

Articles

License

Copyright (c) 2023 Ivaylo Alexiev, Ivan Ivanov, Ivan Stoikov, Deyan Donchev, Lyubomira Grigorova, Reneta Dimitrova, Anna Gancheva, Neli Korsun, Ivelina Trifonova, Veselin Dobrinov, Todor Kantardjiev , Iva Christova (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

CC-BY 4.0

How to Cite

(1)
Alexiev, I.; Ivanov, I.; Stoikov, I.; Donchev, D.; Grigorova, L.; Dimitrova, R.; Gancheva, A.; Korsun, N.; Trifonova, I.; Dobrinov, V.; Kantardjiev , T.; Christova, I. SARS-COV-2 GENOMIC SURVEILLANCE IN BULGARIA INDICATES DIVERSE DYNAMICS DRIVEN BY MULTIPLE INTRODUCTIONS OF DIFFERENT VIRAL VARIANTS IN 2022. Probl Infect Parasit Dis 2023, 50 (3), 5-13. https://doi.org/10.58395/6725v303.

Most read articles by the same author(s)

1 2 3 > >>